The association of CXCL10 with CXCR3 increases tumor proliferation and migration and plays a role in the metastasis mechanism, so, in the future, CXCL10 can be used both in HCV-associated HCC screening, and there is a possibility that CXCL10-targeting therapies can be used in the treatment of HCV-associated HCC [37]. This evidence concerns the gene CXCL10 and hepatocellular carcinoma.